These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12179178)

  • 21. Estrogen component of OCs.
    Kaunitz AM; Ory H
    Dialogues Contracept; 1997; 5(4):1-6. PubMed ID: 12293158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and coronary heart disease.
    Ettinger B
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):741-57. PubMed ID: 2092240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What we know about estrogen's effect on the brain.
    Mitchell JL
    Curr Womens Health Rep; 2002 Oct; 2(5):382-9. PubMed ID: 12215311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to end bias against the pill.
    Potts M
    Entre Nous Cph Den; 1992 May; (20):10-1. PubMed ID: 12222224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
    Rossouw JE
    Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A
    Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
    Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
    Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone therapy and coronary heart disease in young women.
    Weiner MG; Barnhart K; Xie D; Tannen RL
    Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estrogens and cancer of the endometrium (author's transl)].
    Wolff JP; George M
    Contracept Fertil Sex (Paris); 1980 Mar; 8(3):245-9. PubMed ID: 12309741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged estrogen therapy in postmenopausal women.
    Wallach S; Henneman PH
    J Am Med Assoc; 1959 Nov; 171(12):1637-42. PubMed ID: 12305488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
    Shapiro S
    Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.